Last $3.86 USD
Change Today +0.15 / 4.04%
Volume 697.2K
ZIOP On Other Exchanges
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathan J. Lewis M.D., Ph.D.

Chief Executive Officer and Director, ZIOPHARM Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Jonathan J. Lewis, MD., PhD., has been the Chief Executive Officer of Ziopharm Oncology, Inc. since January 2004. Dr. Lewis served as the Chief Medical Officer of Ziopharm Oncology, Inc. from June 2008 to June 2011. He served as the Chief Executive Officer of Ziopharm Inc. since January 2004. He served as the Chief Medical Officer of Antigenics Inc. from June 2000 to Noveber 2003. He joined Antigenics from Memorial Sloan-Kettering Cancer Center in New York, where ...

Read Full Background

Corporate Headquarters*

Parris Building
Boston, Massachusetts 02129

United States

Phone: 617-259-1970
Fax: 617-241-2855

Board Members Memberships*

Chief Executive Officer and Director
Former Director, Chairman of Compensation & Stock Option Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee


University of the Witwatersrand
University of the Witwatersrand
Yale University School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$600,000

Stock Options*

All Other Compensation$91,992
Exercisable Options1,289,918
Exercisable Options Value$1,915,220
Unexercisable Options830,000
Unexercisable Options Value$709,200
Total Value of Options$2,624,420
Total Number of Options2,119,918

Total Compensation*

Total Annual Cash Compensation$691,992
Total Short Term Compensation$600,000
Other Long Term Compensation$91,992
Total Calculated Compensation$1,692,672
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZIOP:US $3.86 USD +0.15


Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary and Director
GenVec, Inc.
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZIOPHARM ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at